131 related articles for article (PubMed ID: 37897858)
1. Association of sarcopenia with oncologic outcomes of primary treatment among patients with oral cavity cancer: A systematic review and meta-analysis.
Graves JP; Daher GS; Bauman MMJ; Moore EJ; Tasche KK; Price DL; Van Abel KM
Oral Oncol; 2023 Dec; 147():106608. PubMed ID: 37897858
[TBL] [Abstract][Full Text] [Related]
2. The impact of sarcopenia on tolerance of radiation and outcome in patients with head and neck cancer receiving chemoradiation.
Ganju RG; Morse R; Hoover A; TenNapel M; Lominska CE
Radiother Oncol; 2019 Aug; 137():117-124. PubMed ID: 31085391
[TBL] [Abstract][Full Text] [Related]
3. Skeletal muscle mass at C3 may not be a strong predictor for skeletal muscle mass at L3 in sarcopenic patients with head and neck cancer.
Yoon JK; Jang JY; An YS; Lee SJ
PLoS One; 2021; 16(7):e0254844. PubMed ID: 34280248
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of sarcopenia and sarcopenic obesity in patients affected by oral squamous cell carcinoma: A retrospective single-center study.
Bonavolontà P; Improta G; Dell'Aversana Orabona G; Goglia F; Abbate V; Sorrentino A; Piloni S; Salzano G; Iaconetta G; Califano L
J Craniomaxillofac Surg; 2023 Jan; 51(1):7-15. PubMed ID: 36739189
[TBL] [Abstract][Full Text] [Related]
5. Nutritional status and skeletal muscle status in patients with head and neck cancer: Impact on outcomes.
Findlay M; White K; Brown C; Bauer JD
J Cachexia Sarcopenia Muscle; 2021 Dec; 12(6):2187-2198. PubMed ID: 34676673
[TBL] [Abstract][Full Text] [Related]
6. Is sarcopenia a predictor of prognosis for patients undergoing radiotherapy for head and neck cancer? A meta-analysis.
Findlay M; White K; Stapleton N; Bauer J
Clin Nutr; 2021 Apr; 40(4):1711-1718. PubMed ID: 32994071
[TBL] [Abstract][Full Text] [Related]
7. The Impact of Skeletal Muscle Depletion on Head and Neck Squamous Cell Carcinoma.
Nishikawa D; Hanai N; Suzuki H; Koide Y; Beppu S; Hasegawa Y
ORL J Otorhinolaryngol Relat Spec; 2018; 80(1):1-9. PubMed ID: 29393251
[TBL] [Abstract][Full Text] [Related]
8. Feasibility of using head and neck CT imaging to assess skeletal muscle mass in head and neck cancer patients.
Swartz JE; Pothen AJ; Wegner I; Smid EJ; Swart KM; de Bree R; Leenen LP; Grolman W
Oral Oncol; 2016 Nov; 62():28-33. PubMed ID: 27865369
[TBL] [Abstract][Full Text] [Related]
9. Impact of sarcopenia in locally advanced head and neck cancer treated with chemoradiation: An Indian tertiary care hospital experience.
Nagpal P; Pruthi DS; Pandey M; Yadav A; Singh H
Oral Oncol; 2021 Oct; 121():105483. PubMed ID: 34403887
[TBL] [Abstract][Full Text] [Related]
10. Sarcopenia results in poor survival rates in oral cavity cancer patients.
Lin SC; Lin YS; Kang BH; Yin CH; Chang KP; Chi CC; Lin MY; Su HH; Chang TS; She YY; Liu YH; Lee CC
Clin Otolaryngol; 2020 May; 45(3):327-333. PubMed ID: 31769607
[TBL] [Abstract][Full Text] [Related]
11. Impact of sarcopenia and myosteatosis on survival outcomes for patients with head and neck cancer undergoing curative-intent treatment.
Ahern E; Brown TE; Campbell L; Hughes BGM; Banks M; Lin CY; Kenny LM; Bauer J
Br J Nutr; 2023 Feb; 129(3):406-415. PubMed ID: 35152926
[TBL] [Abstract][Full Text] [Related]
12. Sarcopenia as a predictor of poor surgical and oncologic outcomes after abdominal surgery for digestive tract cancer: A prospective cohort study.
Zhang S; Tan S; Jiang Y; Xi Q; Meng Q; Zhuang Q; Han Y; Sui X; Wu G
Clin Nutr; 2019 Dec; 38(6):2881-2888. PubMed ID: 30630709
[TBL] [Abstract][Full Text] [Related]
13. Impact of Sarcopenia on Outcomes of Autologous Head and Neck Free Tissue Reconstruction.
Alwani MM; Jones AJ; Novinger LJ; Pittelkow E; Bonetto A; Sim MW; Moore MG; Mantravadi AV
J Reconstr Microsurg; 2020 Jun; 36(5):369-378. PubMed ID: 32088918
[TBL] [Abstract][Full Text] [Related]
14. Sarcopenia supersedes subjective global assessment as a predictor of survival in colorectal cancer.
Vashi PG; Gorsuch K; Wan L; Hill D; Block C; Gupta D
PLoS One; 2019; 14(6):e0218761. PubMed ID: 31220163
[TBL] [Abstract][Full Text] [Related]
15. Impact of body composition parameters on clinical outcomes in patients with metastatic castrate-resistant prostate cancer treated with docetaxel.
Cushen SJ; Power DG; Murphy KP; McDermott R; Griffin BT; Lim M; Daly L; MacEneaney P; O' Sullivan K; Prado CM; Ryan AM
Clin Nutr ESPEN; 2016 Jun; 13():e39-e45. PubMed ID: 28531567
[TBL] [Abstract][Full Text] [Related]
16. Detection of sarcopenic obesity and prediction of long-term survival in patients with gastric cancer using preoperative computed tomography and machine learning.
Kim J; Han SH; Kim HI
J Surg Oncol; 2021 Dec; 124(8):1347-1355. PubMed ID: 34490899
[TBL] [Abstract][Full Text] [Related]
17. Masticatory muscle index for indicating skeletal muscle mass in patients with head and neck cancer.
Chang SW; Tsai YH; Hsu CM; Huang EI; Chang GH; Tsai MS; Tsai YT
PLoS One; 2021; 16(5):e0251455. PubMed ID: 33970954
[TBL] [Abstract][Full Text] [Related]
18. Evaluating the prognosis of oral squamous cell carcinoma patients via L3 skeletal muscle index.
Lu X; Tian Y; Huang J; Li F; Shao T; Huang G; Lv X
Oral Dis; 2023 Apr; 29(3):923-932. PubMed ID: 34773352
[TBL] [Abstract][Full Text] [Related]
19. Sarcopenia and Systemic Inflammation Synergistically Impact Survival in Oral Cavity Cancer.
Lee J; Liu SH; Dai KY; Huang YM; Li CJ; Chen JC; Leu YS; Liu CJ; Chen YJ
Laryngoscope; 2021 May; 131(5):E1530-E1538. PubMed ID: 33135827
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of sarcopenia as a prognostic biomarker in locally advanced head and neck squamous cell carcinoma.
Erul E; Guven DC; Ozbay Y; Altunbulak AY; Kahvecioglu A; Ercan F; Yesil MF; Ucdal MT; Cengiz M; Yazici G; Kuscu O; Suslu N; Gullu I; Onur MR; Aksoy S
Biomark Med; 2023 Jan; 17(2):87-99. PubMed ID: 37042459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
